Merit Medical Systems (MMSI) Stock Price, News & Analysis

-0.37 (-0.45%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
287,535 shs
Average Volume
474,752 shs
Market Capitalization
$4.76 billion
P/E Ratio
Dividend Yield
Price Target

Merit Medical Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.89 Rating Score
13.3% Upside
$92.78 Price Target
Short Interest
3.89% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
1.02mentions of Merit Medical Systems in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$3.75 M Sold Last Quarter
Proj. Earnings Growth
From $3.33 to $3.65 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.64 out of 5 stars

Medical Sector

70th out of 922 stocks

Surgical & Medical Instruments Industry

11th out of 95 stocks

MMSI stock logo

About Merit Medical Systems Stock (NASDAQ:MMSI)

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

MMSI Stock Price History

MMSI Stock News Headlines

Merit Medical Executive Leadership Team Update
Men of Merit: UCI Health
The Analyst Landscape: 11 Takes On Merit Medical Systems
Merit Medical: Q1 Earnings Snapshot
Piper Sandler Keeps Their Buy Rating on Merit Medical Systems (MMSI)
Decoding 7 Analyst Evaluations For Merit Medical Systems
MMSI Oct 2024 50.000 put
See More Headlines
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Supplies
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
9 Analysts


Net Income
$94.41 million
Pretax Margin


Sales & Book Value

Annual Sales
$1.26 billion
Cash Flow
$4.72 per share
Book Value
$21.34 per share


Free Float
Market Cap
$4.76 billion

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

MMSI Stock Analysis - Frequently Asked Questions

Should I buy or sell Merit Medical Systems stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MMSI shares.
View MMSI analyst ratings
or view top-rated stocks.

What is Merit Medical Systems' stock price target for 2024?

9 Wall Street analysts have issued 1 year price targets for Merit Medical Systems' shares. Their MMSI share price targets range from $85.00 to $102.00. On average, they anticipate the company's share price to reach $92.78 in the next year. This suggests a possible upside of 13.3% from the stock's current price.
View analysts price targets for MMSI
or view top-rated stocks among Wall Street analysts.

How have MMSI shares performed in 2024?

Merit Medical Systems' stock was trading at $75.96 at the beginning of the year. Since then, MMSI shares have increased by 7.8% and is now trading at $81.89.
View the best growth stocks for 2024 here

When is Merit Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 23rd 2024.
View our MMSI earnings forecast

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) released its quarterly earnings data on Tuesday, April, 30th. The medical instruments supplier reported $0.77 EPS for the quarter, topping the consensus estimate of $0.71 by $0.06. The medical instruments supplier earned $323.51 million during the quarter, compared to the consensus estimate of $315.57 million. Merit Medical Systems had a net margin of 7.94% and a trailing twelve-month return on equity of 15.02%. The business's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.64 earnings per share.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY 2024 earnings guidance on Tuesday, April, 30th. The company provided earnings per share (EPS) guidance of 3.280-3.350 for the period, compared to the consensus EPS estimate of 3.320. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.74%), William Blair Investment Management LLC (5.24%), Conestoga Capital Advisors LLC (3.75%), Westwood Holdings Group Inc. (1.51%), Price T Rowe Associates Inc. MD (1.44%) and Congress Asset Management Co. MA (0.89%). Insiders that own company stock include A Scott Anderson, Brian G Lloyd, F Ann Millner, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Michel James Voigt, Neil Peterson, Raul Jr Parra, Ronald Frost and Thomas James Gunderson.
View institutional ownership trends

How do I buy shares of Merit Medical Systems?

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Merit Medical Systems have any subsidiaries?
The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.
Read More
This page (NASDAQ:MMSI) was last updated on 5/18/2024 by Staff

From Our Partners